Pendapatan tahunan perusahaan Protara Therapeutics, Inc. (TARA)

Simbol lan logo merek protaratx.com (TARA)

Protara Therapeutics (TARA) faces risks related to dependence on external investment and a narrow patient segment. The GURU.Markets interface displays the company's current performance metrics, where the latest value is recorded as 0.00. Stability is provided by US laboratories specializing in the treatment of rare tumors. The retention of qualified R&D specialists is guaranteed through stock options, protecting the business's scientific potential from competition.

Protara Therapeutics, Inc. (TARA) - Pendapatan perusahaan saka 04.07.2022 nganti 14.11.2026

Rincian metrik komprehensif lan analitis Protara Therapeutics, Inc. (TARA)

- rega pasar lan target rega analis:
Rega bursa Protara Tx|TARA - Bagan rega target
- rincian kapitalisasi pasar:
Biji pasar Protara Therapeutics, Inc.|TARA - Nilai Total Perusahaan
- rincian valuasi buku bisnis:
Nilai Akuntansi Saham Protara Therapeutics|TARA - Nilai Buku Perusahaan|Koefisien Nilai Pasar marang Nilai Buku protaratx.com|TARA - Gunggung Aset Perusahaan
- data liabilitas lan likuiditas perusahaan:
Utang Agregat marang Modal Protara Therapeutics|TARA - Utang jangka dawa marang modal|Utang jangka cendhak marang modal Protara Therapeutics Inc|TARA - Utang perusahaan|Rasio utang marang aset resik Protara Therapeutics, Inc.|TARA - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Protara Therapeutics|Rasio jangkoan perantara protaratx.com
- indikator bathi lan kelipatan valuasi:
TARA - Penghasilan resik|Bathi resik mangsa ngarep Protara Therapeutics|TARA - Pangali P/E|Pangali mangsa ngarep rega marang bathi protaratx.com|TARA - Pangali PEG|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Protara Therapeutics, Inc.|TARA - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi saben saham sajroning taun lumaku Protara Therapeutics|TARA - Bathi resik saben saham (EPS TTM)|Wutah bathi EPS kuartalan protaratx.com|TARA - Wutah bathi saben saham ing taun lumaku|Prakiraan owah-owahan bathi resik saben saham kanggo taun ngarep Protara Therapeutics
- indikator volume dodolan lan pendapatan:
TARA - Pendapatan lan volume dodolan|Volume dodolan sing dikarepake perusahaan Protara Tx|TARA - Kapitalisasi marang pendapatan|Multiplikator Forward P/S Protara Therapeutics, Inc.
Analisis komprehensif perusahaan:Protara Tx - TARA
Produk dadi Protara Therapeutics, Inc.

This indicator tracks the daily inflow of commercial funds, allowing for a real-time assessment of demand stability. Investors diagnose the fundamental reliability of an asset by monitoring deviations of current inflows from the norm. Analyzing the company's sales revenue can reveal signs of local price overheating. For Protara Therapeutics (TARA), this price action reflects the effectiveness of monetizing its developments. The company is currently implementing robotic automation for molecule screening to accelerate the creation of oncology drugs.

Pesaing wigati

Total pendapatan perusahaan BeiGene Oncology ONC|Pendapatan perusahaan Halozyme Therapeutics (HALO)|RVMD: Pendapatan tahunan perusahaan|Pendapatan perusahaan Ascentage Pharma AAPG|Pendapatan dodolan perusahaan CGON|URGN - Pendapatan perusahaan|Total pendapatan perusahaan Bicara Corp|PSNL (Personalis, Inc.) - Dodolan perusahaan|ERAS: Total dodolan perusahaan|DCTH (Delcath Systems) - Pendapatan lan volume dodolan|Pendapatan lan volume dodolan Y-mAbs Therapeutics Inc|Pendapatan perusahaan Aura Bio (AURA)|CADL (candeltx.com) - Pendapatan dodolan perusahaan|Pendapatan lan volume dodolan ARAY (Accuray Incorporated)|Pendapatan lan volume dodolan SELLAS Life Sciences Group, Inc. SLS|ACTU: Dodolan perusahaan|Pendapatan dodolan perusahaan CTOR (Citius Oncology Inc.)|HURA (tuhurabio.com) - Dodolan perusahaan|FATE: Total dodolan perusahaan|WHWK (Aadi Bioscience, Inc.) - Pendapatan lan volume dodolan|TCRX: Pendapatan dodolan perusahaan|Pendapatan lan volume dodolan CSBR|XBIT - Total pendapatan perusahaan|Pendapatan perusahaan CEL-SCI CVM|Pendapatan dodolan perusahaan OSTX|Radiopharm Theranostics Limited - Pendapatan lan volume dodolan|ARTV - Pendapatan lan volume dodolan|adlainortye.com (ANL) - Pendapatan perusahaan|Pendapatan tahunan perusahaan VERU (Veru Inc)|TPST (Tempest Tx) - Pendapatan lan volume dodolan|Total pendapatan perusahaan Xilio XLO|Dodolan perusahaan RENB (Renovaro Inc.)|Pendapatan lan volume dodolan muraloncology.com (MURA)|Kairos Pharma - Dodolan perusahaan|Total dodolan perusahaan OKUR (OnKure Therapeutics, Inc.)|CytoMed - Pendapatan lan volume dodolan|Pendapatan reged perusahaan Curis, Inc. CRIS|APLM: Pendapatan lan volume dodolan|Dodolan perusahaan tharimmune.com|Pendapatan perusahaan Advanced Biomed Inc.|Genprex Inc. (GNPX) - Pendapatan reged perusahaan|Dodolan perusahaan CLDI (Calidi Biotherapeutics)|Total dodolan perusahaan SBFM|Pendapatan lan volume dodolan XBIO (Xenetic Biosciences, Inc.)|Pendapatan lan volume dodolan salariuspharma.com SLRX|PPBT - Pendapatan perusahaan|Pendapatan dodolan perusahaan AONC (American Oncology Network)|BGNE: Pendapatan lan volume dodolan|Checkpoint Therapeutics Inc (CKPT) - Pendapatan lan volume dodolan|ELEV (Elevation Oncology, Inc.) - Pendapatan lan volume dodolan|Dodolan perusahaan iCAD Corp (ICAD)|Pendapatan lan volume dodolan IKNA|Pendapatan lan volume dodolan Notable Labs Ltd (NTBL)|Pendapatan perusahaan Viracta Therapeutics, Inc. VIRX|MOR: Volume dodolan perusahaan|NAYA Biosciences - Pendapatan lan volume dodolan|ascentage.com (AAPGV) - Dodolan perusahaan